These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5741236)

  • 1. [Treatment of light-induced hyperpigmentation of the skin with hydroquinone monobenzyl ester].
    Lur'e VG; Lur'e IV
    Vestn Dermatol Venerol; 1968 Feb; 42(2):84-6. PubMed ID: 5741236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
    Gusarova AS; Zalem ZIa
    Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperpigmentations of the skin with hydroguinone (depigmentation ointment)].
    Peisert E; Król C
    Przegl Dermatol; 1972; 59(2):205-9. PubMed ID: 5023356
    [No Abstract]   [Full Text] [Related]  

  • 4. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
    McGuinn KP; Saedi N; Green JB; Dover JS
    Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of a pigmented lesion induced by a Pelagia noctiluca sting.
    Kokelj F; Burnett JW
    Cutis; 1990 Jul; 46(1):62-4. PubMed ID: 1974491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods and means for pigmentation and depigmentation. Sense or nonsense?].
    Hegyi V; Hegyi J
    Hautarzt; 2010 Jul; 61(7):586-92. PubMed ID: 20549480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of melanin-induced pigment anomalies].
    Herzberg JJ
    Hautarzt; 1985 Nov; 36(11):635-8. PubMed ID: 3908403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical experiences with a hydroquinone monobenzylether preparation and a sunscreening agent in hyperpigmentations and light dermatoses].
    Jung HD
    Z Haut Geschlechtskr; 1967 Sep; 42(17):711-6. PubMed ID: 5593108
    [No Abstract]   [Full Text] [Related]  

  • 10. A new formula for depigmenting human skin.
    Kligman AM; Willis I
    Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpigmentation improved by treatment with monobenzyl ether of hydroquinone.
    POLLOCK JH
    Arch Derm Syphilol; 1950 May; 61(5):873-5. PubMed ID: 15411240
    [No Abstract]   [Full Text] [Related]  

  • 12. Pigmented skin lesions; treatment with monobenzyl-ether of hydroquinone.
    KELLY EW
    J Mich State Med Soc; 1956 Mar; 55(3):303-4; passim. PubMed ID: 13307208
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
    Tezuka T; Saheki M; Kusuda S; Umemoto K
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis.
    Clarys P; Barel A
    J Dermatol; 1998 Jun; 25(6):412-4. PubMed ID: 9675352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dyschromias in ethnic skin.
    Halder RM; Richards GM
    Dermatol Ther; 2004; 17(2):151-7. PubMed ID: 15113282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical chemotherapy of pigment abnormalities in surgical patients.
    Gilchrest BA; Goldwyn RM
    Plast Reconstr Surg; 1981 Apr; 67(4):435-9. PubMed ID: 7208685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation.
    Petit L; Piérard GE
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):546-9. PubMed ID: 12941090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical use of hydroquinone for depigmentation.
    Spencer MC
    JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation.
    Bentley-Phillips B; Bayles MA
    S Afr Med J; 1975 Aug; 49(34):1391-5. PubMed ID: 1162515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired leukomelanoderma caused by topical depigmenting agents].
    Grojean MF; Thivolet J; Perrot H
    Ann Dermatol Venereol; 1982; 109(8):641-7. PubMed ID: 7187189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.